Profile of kidney function markers in patients with COVID-19 hospitalized in the ICU of a hospital in the middle west of Santa Catarina
DOI:
https://doi.org/10.33448/rsd-v11i15.37277Keywords:
COVID-19; ICU; Nephrotoxicity; Pharmacotherapy; Biochemical markers.Abstract
The viral disease called COVID-19, caused by the Sars-Cov-2 virus, had its first records in the city of Wuhan, China, in December 2019. Because it is a disease with respiratory symptoms, a high rate of contagion and gradual worsening, made COVID-19 the biggest pandemic in recent times. The complications of the disease required treatment in Intensive Care Units (ICU) for its most serious victims, which led to a series of events and complications resulting from the junction of the pathology with the consequences of the treatment. This article aims to evaluate, through statistical analysis of medical records and laboratory test reports, the biochemical profile of renal markers in patients hospitalized in the ICU, looking for correlations between the therapy used and the length of stay of these patients. Significant alterations were observed in renal markers, mainly urea, and creatinine, in patients who remained hospitalized for a longer time, concerning the others. Furthermore, all patients were treated with drugs that expressed nephrotoxic characteristics. Finally, a positive correlation between the length of stay of these patients in the ICU, with prolonged exposure to nephrotoxic drugs and kidney damage, can be found.
References
Besen, B. A. M. P. (2021). Abordagem clínica do paciente com SRAG por Covid-19. Cuidados Especializados, 61–81. www.conass.org.br/biblioteca.
Brasil, Ministério da Saúde. (2022). Coronavírus Brasil. Covid.saude.gov.br. https://covid.saude.gov.br/
Brasil, Ministério da Saúde. (2021). Diretrizes Brasileiras para Tratamento Hospitalar do Paciente com COVID-19 – Capítulo 2: Tratamento Farmacológico. http://conitec.gov.br/images/Consultas/Relatorios/2021/20210517_Relatorio_Diretrizes_Brasileiras_COVID_Capitulo_2_CP_37.pdf
Carvalho, L. F., Paula, T. C. G. Q. de, & Peixoto, V. S. (2021). Acute kidney injury in patients diagnosed with COVID-19 in an ICU in southwestern Goiás. Research, Society and Development, 10(17), e157101724492–e157101724492. https://doi.org/10.33448/RSD-V10I17.24492
Denizarde, I. (2018). GEN Medicina | Drogas vasoativas e o rim - Academia de Medicina. https://www.academiademedicina.com.br/genmedicina/drogas-vasoativas-e-o-rim
Estrela, C. (2018). Metodologia Científica: Ciência, Ensino, Pesquisa. Editora Artes Médicas.
Guerini, I. S., Werlang, M. H. B., Wendt, G. W., Casaril, K. B. P. B., & Ferreto, L. E. D. (2022). Coinfecções bacterianas multirresistentes e prática de prescrição de antibióticos em adultos com covid-19: um estudo caso controle. RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218, 3(8), e381814–e381814. https://doi.org/10.47820/RECIMA21.V3I8.1814
Lee, D. Y., Han, K., Yu, J. H., Park, S., Heo, J. I., Seo, J. A., Kim, N. H., Yoo, H. J., Kim, S. G., Kim, S. M., Choi, K. M., Baik, S. H., Park, Y. G., & Kim, N. H. (2020). Gamma-glutamyl transferase variability can predict the development of end-stage of renal disease: a nationwide population-based study. Scientific Reports 2020 10:1, 10(1), 1–9. https://doi.org/10.1038/s41598-020-68603-0
Lloret, M. J., Bover, J., DaSilva, I., Furlano, M., Ruiz-García, C., Ayasreh, N., Quílez, B., Díaz, J. M., & Ballarín, J. A. (2013). Papel del fósforo en la enfermedad renal crónica. Nefrología (English Edition), 4(2), 2–10. https://doi.org/10.3265/NEFROLOGIASUPLEMENTOEXTRAORDINARIO.PRE2013.MAR.11984
Mello, P. A. de, Rocha, B. G., Oliveira, W. N., Mendonça, T. S., & Domingueti, C. P. (2021). Nefrotoxicidade e alterações de exames laboratoriais por fármacos: revisão da literatura. Revista de Medicina, 100(2), 152–161. https://doi.org/10.11606/ISSN.1679-9836.V100I2P152-161
Mendonça, L. B. D. A., Madeiro, A. C., Lima, F. E. T., Barbosa, I. V., De Brito, M. E. M., & Da Cunha, L. G. P. (2011). The use of catecholamines in patients at an intensive care unit. Revista de Enfermagem UFPE on Line, 6(1), 26. https://doi.org/10.5205/reuol.2052-14823-1-le.0601201204
Mercês, S. O. das, Lima, F. L. O., & Vasconcellos Neto, J. R. T. de. (2020). Association of COVID-19 with: age and medical comorbidities. Research, Society and Development, 9(10), e1299108285–e1299108285. https://doi.org/10.33448/RSD-V9I10.8285
Our World in Data. (2022). COVID-19 Data Explorer. Our World in Data. https://ourworldindata.org/explorers/coronavirus-data-explorer
Reis, K. N., Martins De Oliveira Filho, J., Da, F., & Borges, S. (2022). Alterações hematológicas, bioquimícas e funcionais entre adultos e idosos internados com Covid-19 em Brasília-DF. Health Residencies Journal HRJ, 3(15), 306–332. https://doi.org/10.51723/HRJ.V3I15.479
Rossi, F. H. (2020). Tromboembolismo venoso em pacientes COVID-19. Jornal Vascular Brasileiro, 19, 1–5. https://doi.org/10.1590/1677-5449.200107
Saavedra, P. A. E., Cañás, M., Barbado, D. M. C., Esparza, L. B., Caffaratti, M., Speranza, N., Martínez, C. F., & Guitiérrez, J. J. L. (2020). Tratamiento farmacológico para COVID-19 en protocolos latinoamericanos: Una revisión narrativa de la eficacia y seguridad. Vigilância Sanitária Em Debate: Sociedade, Ciência & Tecnologia, 8(3), 150–160. https://doi.org/10.22239/2317-269X.01741
Sampaio, L. A., Silva, F. M. L., & Ramos, M. H. T. (2021). The impacts on Hospital Corporate Education with the emergence of COVID-19: an integrative review. Research, Society and Development, 10(1), e54110112094–e54110112094. https://doi.org/10.33448/RSD-V10I1.12094
Souza, W. C., Peixe, R. G., Sodré, M. C., & Antunes, A. P. (2021). Cost assessment of pharmacotherapy applied to patients affected by COVID-19 under invasive mechanical ventilation in a general hospital. Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde, 12(4), 641–641. https://doi.org/10.30968/RBFHSS.2021.124.0641
Vieira, A. D. C., Rodrigues, A. D. & Rahmeier, F. L. et al. (2021). Bioquímica clínica: líquidos exclusivos. Grupo A. https://integrada.minhabiblioteca.com.br/books/9786556901077".
Vieira, F., Bordignon, J., & Linartevichi, V. F. (2021). Análise comparativa do consumo de sedativos durante o internamento em UTI COVID-19. Research, Society and Development, 10(13), e416101321371. https://doi.org/10.33448/rsd-v10i13.21371
WHO. (2022). Coronavirus (COVID-19) Dashboard. WHO Coronavirus (COVID-19) Dashboard With Vaccination Data. https://covid19.who.int/".
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., Guan, L., Wei, Y., Li, H., Wu, X., Xu, J., Tu, S., Zhang, Y., Chen, H., & Cao, B. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet, 395(10229), 1054–1062. https://doi.org/10.1016/S0140-6736(20)30566-3
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Julia Tristão de Souza; Paula Otávia Haacke Branco; Jackson de Moura; Emyr Hiago Bellaver
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
